GO:0140374 antiviral innate immune response: Defense Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140374 antiviral innate immune response is defined as a defense response against viruses mediated through germline-encoded innate immune components that directly recognize pathogen components.
• The response is initiated by germline-encoded sensors such as RIG-I-like receptors, cGAS-STING, and RNA polymerase III, which detect viral nucleic acids and trigger interferon and inflammatory signaling.
• Viruses counteract this response through diverse evasion strategies, including autophagy induction, mitophagy, deubiquitination, and inhibition of STING stability.
• Key effector genes include IFNs, ISGs, STING1, MAVS, TBK1, IRF3, and inflammasome components, many of which are conserved across vertebrates including fish and mammals.
• Dysregulation of antiviral innate immunity contributes to severe viral disease, including SARS-CoV-2 pathogenesis and inflammasome-mediated inflammation.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of antiviral innate immune genes in vitro and in vivo.
Description
The Gene Ontology term GO:0140374, antiviral innate immune response, describes a defense response against viruses that is mediated through an innate immune response, which relies on germline-encoded components that directly recognize components of potential pathogens. This term captures the earliest line of host defense against viral infection, operating within minutes to hours of pathogen detection and preceding adaptive immunity. Understanding this process is central to virology, immunology, and therapeutic development because it determines viral clearance, disease severity, and vaccine efficacy. The antiviral innate immune response is triggered when germline-encoded sensors detect viral nucleic acids, proteins, or structural components. This recognition activates signaling cascades that culminate in the production of type I interferons, proinflammatory cytokines, and interferon-stimulated genes, which collectively restrict viral replication and spread. The response is tightly regulated, and viruses have evolved numerous countermeasures, including autophagy-mediated escape, mitophagy induction, and deubiquitination of signaling intermediates. Researchers study GO:0140374 to identify host factors that control viral infection, to understand viral evasion mechanisms, and to develop host-directed antivirals and immunomodulatory therapies. The term is also relevant to comparative immunology, as core antiviral genes are conserved across fish, livestock, poultry, and humans.
antiviral innate immune response At A Glance
| GO ID | GO:0140374 |
|---|---|
| GO term | antiviral innate immune response |
| Ontology | biological_process |
| Synonym | None |
| Definition | A defense response against viruses mediated through an innate immune response. An innate immune response is mediated by germline encoded components that directly recognize components of potential pathogens. |
| Major function | Detection and restriction of viral infection through germline-encoded sensors and effector molecules |
| Related processes | Interferon signaling, inflammasome activation, autophagy, mitophagy, RNA polymerase III sensing |
| Taxonomic scope | Conserved across vertebrates including mammals, fish, livestock, and poultry |
What Is GO:0140374?
In our own words, GO:0140374 antiviral innate immune response refers to the set of biological processes by which a host organism defends itself against viruses using innate immune mechanisms. These mechanisms are encoded in the germline and directly recognize viral components, such as nucleic acids or proteins, without prior exposure to the pathogen. The response includes detection of viral molecules, signal transduction, production of antiviral effectors such as interferons and cytokines, and downstream restriction of viral replication.
Why Is antiviral innate immune response Important in Cell Biology?
GO:0140374 is critically important because the antiviral innate immune response determines the outcome of viral infections, from asymptomatic clearance to severe disease. It provides the first line of defense that limits viral replication before adaptive immunity is engaged, and its dysregulation is associated with immunopathology, chronic inflammation, and viral immune evasion. Understanding this process at the molecular level informs the development of broad-spectrum antivirals, vaccine adjuvants, and host-directed therapies, and it is essential for interpreting viral pathogenesis in humans and animals.
• Provides the first line of host defense against viral infection and limits viral spread before adaptive immunity.
• Germline-encoded sensors such as RIG-I-like receptors and cGAS-STING directly recognize viral nucleic acids.
• Type I interferons and interferon-stimulated genes are key effectors that restrict viral replication.
• Viruses evade this response through autophagy, mitophagy, and deubiquitination, making it a target for antiviral drug development.
• Dysregulation contributes to severe COVID-19 and inflammasome-mediated inflammatory pathology.
• Conserved across fish, livestock, and poultry, with relevance to aquaculture and veterinary medicine.
• RNA polymerase III acts as a sensor of viral DNA and contributes to antiviral innate immunity.
• STING stability regulated by UFL1 is essential for effective antiviral signaling.
• Inflammasome activation during SARS-CoV-2 infection links innate immunity to inflammatory disease.
• CRISPR-based models enable causal testing of host genes in antiviral innate immunity.
What Happens During antiviral innate immune response?
Viral recognition by germline-encoded sensors
In simple terms: The body has pre-made alarm sensors that spot pieces of viruses as soon as they enter a cell.
The antiviral innate immune response begins when germline-encoded pattern recognition receptors detect viral components such as RNA, DNA, or proteins. RNA polymerase III can sense viral DNA and produce RNA ligands that activate innate immune signaling. Cytosolic sensors including RIG-I-like receptors and cGAS-STING detect viral nucleic acids and initiate downstream signaling. This recognition step is essential for distinguishing viral from self molecules and for triggering a rapid defense response.
Signal transduction and interferon induction
In simple terms: Once a virus is detected, a chain of molecular signals turns on antiviral genes.
Following detection, adaptor proteins such as STING1 and MAVS transmit signals to kinases including TBK1, which activate transcription factors such as IRF3 and NF-kB. These transcription factors drive the expression of type I interferons and proinflammatory cytokines. UFL1 promotes antiviral immune response by maintaining STING stability independent of UFMylation, highlighting the importance of stabilizing signaling intermediates. The resulting interferon response induces hundreds of interferon-stimulated genes that establish an antiviral state.
Effector mechanisms and viral restriction
In simple terms: Antiviral proteins made by the cell directly block the virus from copying itself.
Interferon-stimulated gene products directly restrict viral replication at multiple stages, including entry, genome replication, and assembly. In fish, five major antiviral genes have been characterized as key effectors of the innate response to viral infection. Inflammasome activation during SARS-CoV-2 infection also contributes to antiviral defense but can cause inflammatory pathology. The balance between effective viral restriction and excessive inflammation determines disease outcome.
Viral evasion strategies
In simple terms: Viruses fight back by disabling or escaping the cell's alarm system.
Viruses have evolved diverse mechanisms to evade the antiviral innate immune response. Bunyavirus SFTSV NSs utilizes autophagy to escape the antiviral innate immune response. The nucleoprotein of influenza A virus inhibits the innate immune response by inducing mitophagy. Viral deubiquitinases in livestock and poultry viruses counteract innate antiviral immunity by removing ubiquitin chains from signaling molecules. These evasion strategies are major determinants of viral pathogenesis and are targets for therapeutic intervention.
Regulation and resolution of the response
In simple terms: The alarm system must be turned off after the threat passes to avoid harming the body.
The antiviral innate immune response is tightly regulated to prevent excessive inflammation and autoimmunity. Post-translational modifications, including ubiquitination and deubiquitination, control the stability and activity of signaling intermediates such as STING. Autophagy and mitophagy can either promote antiviral defense or be exploited by viruses to dampen immunity. Proper resolution of the response is essential for restoring tissue homeostasis after viral clearance.
Key Genes Involved in GO:0140374 antiviral innate immune response
The following genes and proteins are central to the antiviral innate immune response and are widely studied using CRISPR-based models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STING1 | Adaptor protein in cytosolic DNA sensing; activates TBK1-IRF3 signaling | Stability regulated by UFL1; target for viral evasion studies |
| MAVS | Mitochondrial adaptor for RIG-I-like receptor signaling | Central node in RNA virus sensing and interferon induction |
| TBK1 | Kinase that phosphorylates IRF3 to induce interferons | Key signaling hub targeted by viral proteins |
| IRF3 | Transcription factor driving type I interferon expression | Essential for antiviral gene induction |
| IFNB1 | Type I interferon cytokine with broad antiviral activity | Effector molecule amplified by STING-MAVS signaling |
| POLR3A | RNA polymerase III subunit that senses viral DNA | Links DNA sensing to innate immunity |
| RIG-I (DDX58) | Cytosolic RNA sensor for short viral RNA | Initiates MAVS-dependent signaling |
| MDA5 (IFIH1) | Cytosolic RNA sensor for long viral RNA | Activates MAVS and interferon responses |
| cGAS (CGAS) | Cytosolic DNA sensor producing cGAMP | Activates STING-dependent signaling |
| NLRP3 | Inflammasome sensor activated during viral infection | Contributes to inflammation in SARS-CoV-2 |
| IL1B | Proinflammatory cytokine processed by inflammasome | Mediates inflammatory pathology during viral infection |
| ATG5 | Autophagy-related protein involved in autophagosome formation | Exploited by SFTSV NSs for immune escape |
| MAP1LC3B | Autophagosomal marker involved in mitophagy | Influenza A nucleoprotein induces mitophagy to inhibit immunity |
| UFL1 | UFM1 ligase that stabilizes STING | Promotes antiviral immunity independent of UFMylation |
| USP family deubiquitinases | Remove ubiquitin from signaling molecules | Viral deubiquitinases counteract innate immunity |
| MX1 | Interferon-stimulated antiviral effector | Conserved antiviral gene in fish and mammals |
| OAS1 | Interferon-stimulated antiviral effector | Activates RNase L to degrade viral RNA |
How Is antiviral innate immune response Regulated?
The antiviral innate immune response is regulated at multiple levels, including post-translational modification, protein stability, and autophagy. UFL1 promotes antiviral immune response by maintaining STING stability independent of UFMylation, demonstrating that stabilization of signaling intermediates is a key regulatory mechanism. Viral deubiquitinases remove ubiquitin chains from host signaling proteins to dampen innate immunity, indicating that ubiquitination is a central regulatory layer. Autophagy and mitophagy can be induced by viral proteins such as SFTSV NSs and influenza A nucleoprotein to escape or inhibit the antiviral response. RNA polymerase III also contributes to regulation by sensing viral DNA and initiating signaling. These regulatory mechanisms ensure that the response is rapid but self-limiting, and their disruption can lead to immunopathology.
antiviral innate immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STING1 | Severe viral infection; interferonopathy | Knockout and point-mutation cell lines to test signaling |
| NLRP3 | SARS-CoV-2-associated hyperinflammation | Knockout macrophages and inflammasome assays |
| ATG5 | Viral evasion via autophagy (SFTSV) | Knockout cells to assess autophagy-dependent escape |
| MAP1LC3B | Influenza A-induced mitophagy and immune inhibition | Knockout and tagged knock-in for mitophagy imaging |
| UFL1 | Antiviral immunity and STING stability | Knockout and overexpression models to test STING stabilization |
Severe viral infections and COVID-19
Dysregulation of the antiviral innate immune response is a hallmark of severe viral infections. SARS-CoV-2 infection and the antiviral innate immune response are closely linked, with inadequate or delayed interferon responses associated with severe COVID-19. Inflammasome activation during SARS-CoV-2 infection contributes to inflammatory pathology and disease severity. Understanding these mechanisms is critical for identifying therapeutic targets and prognostic biomarkers.
Viral immune evasion and chronic infection
Many viruses evade the antiviral innate immune response to establish persistent infection. Bunyavirus SFTSV NSs utilizes autophagy to escape the antiviral innate immune response. Influenza A virus nucleoprotein inhibits innate immunity by inducing mitophagy. Viral deubiquitinases in livestock and poultry viruses counteract innate antiviral immunity, contributing to viral pathogenesis in animals. These evasion strategies are relevant to both human and veterinary medicine.
Inflammatory and autoimmune conditions
Excessive or misdirected antiviral innate immune signaling can cause inflammatory damage. Inflammasome activation during SARS-CoV-2 infection is associated with hyperinflammation and tissue injury. RNA polymerase III and cytosolic DNA sensing pathways can also contribute to autoinflammatory responses when improperly regulated. Balancing antiviral defense with immune tolerance is a major therapeutic challenge.
From antiviral innate immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for interferon induction? | CRISPR knockout cell line followed by viral infection and IFN reporter assay |
| Does a specific phosphorylation site regulate antiviral signaling? | Point-mutation knock-in of the phospho-deficient or phospho-mimetic residue |
| How does a viral protein inhibit innate immunity? | Overexpression of viral protein in wild-type and knockout cells |
| Where does a signaling protein localize during infection? | Tagged knock-in with fluorescent or epitope tag |
| Which host genes control viral replication? | Genome-wide CRISPR library screening |
| Does a gene regulate inflammasome activation? | Knockout and overexpression in macrophages with inflammasome readouts |
How to Study the antiviral innate immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptome changes after viral infection | Identify interferon-stimulated genes and inflammatory pathways |
| Western blot | Protein expression and stability | Assess STING stability and signaling protein levels |
| Immunoprecipitation | Protein-protein interactions and ubiquitination | Study deubiquitinase activity on host proteins |
| Fluorescence microscopy | Subcellular localization and autophagy flux | Monitor mitophagy and autophagosome formation |
| CRISPR knockout screening | Host genes required for antiviral immunity | Discover novel antiviral factors |
| Reporter assays | Interferon and NF-kB promoter activity | Measure innate immune signaling activation |
| Inflammasome assays | Caspase-1 activation and IL-1beta release | Study inflammatory responses during viral infection |
| Comparative genomics | Conservation of antiviral genes across species | Identify conserved effectors in fish and livestock |
Transcriptomic and interferon profiling
RNA sequencing and targeted gene expression panels are used to measure interferon-stimulated genes and inflammatory cytokines after viral infection or innate immune stimulation. These methods reveal the transcriptional output of the antiviral innate immune response and identify genes regulated by sensors such as STING and MAVS. Comparative transcriptomics across species can also highlight conserved antiviral genes.
Protein stability and post-translational modification assays
Western blotting, immunoprecipitation, and ubiquitination assays are used to study the stability and modification of signaling proteins such as STING. UFL1 was shown to promote antiviral immunity by maintaining STING stability independent of UFMylation using these approaches. Viral deubiquitinases can be assayed for their ability to remove ubiquitin from host proteins.
Imaging of autophagy and mitophagy
Fluorescence microscopy and live-cell imaging with autophagosomal markers such as LC3B are used to monitor autophagy and mitophagy during viral infection. SFTSV NSs utilizes autophagy to escape innate immunity, and influenza A nucleoprotein induces mitophagy, both studied by imaging and biochemical assays.
Functional genomics and CRISPR screening
CRISPR knockout and activation screens enable unbiased discovery of host genes that regulate antiviral innate immunity. These screens can identify genes required for interferon induction, viral restriction, or inflammasome activation. Follow-up validation uses targeted knockout, point-mutation, and overexpression models.
How CRISPR Can Be Used to Study GO:0140374 antiviral innate immune response
Knockout
CRISPR knockout cell lines are used to delete candidate antiviral innate immune genes and test their requirement for interferon induction, viral restriction, and inflammasome activation. For example, knockout of STING1 or MAVS abolishes cytosolic nucleic acid sensing and downstream signaling. Knockout of autophagy genes such as ATG5 can reveal whether viral evasion depends on autophagy.
Point Mutation
Point-mutation knock-in models introduce specific amino acid substitutions to test the function of phosphorylation sites, ubiquitination sites, or catalytic residues in antiviral signaling proteins. These models are valuable for dissecting the molecular mechanisms by which UFL1 stabilizes STING or how viral proteins inhibit innate immunity.
Knock-in
Tagged knock-in models add fluorescent or epitope tags to endogenous antiviral genes, enabling real-time imaging and biochemical analysis of protein localization, stability, and interactions during viral infection. Tagged STING or LC3B knock-in cells are useful for studying signaling dynamics and autophagy.
Overexpression
Overexpression models are used to test whether a gene or viral protein is sufficient to activate or inhibit antiviral innate immunity. Overexpression of viral proteins such as SFTSV NSs or influenza A nucleoprotein can suppress innate immune signaling, while overexpression of host factors such as UFL1 can enhance antiviral responses.
How EDITGENE Supports antiviral innate immune response Research
Researchers studying antiviral innate immune response-related genes often need to determine whether a candidate gene is causally involved in viral sensing, signaling, or restriction. EDITGENE provides comprehensive CRISPR-based cell model services to support these investigations, from knockout validation to precise point mutations and tagged knock-ins.
Contact EDITGENE today to design your custom CRISPR model for antiviral innate immune response research.
Frequently Asked Questions About antiviral innate immune response
What is GO:0140374 antiviral innate immune response?
GO:0140374 is a Gene Ontology biological process term defined as a defense response against viruses mediated through an innate immune response, which relies on germline-encoded components that directly recognize pathogen components.
What genes are involved in antiviral innate immune response?
Key genes include STING1, MAVS, TBK1, IRF3, IFNB1, POLR3A, DDX58 (RIG-I), IFIH1 (MDA5), CGAS, NLRP3, IL1B, ATG5, MAP1LC3B, and UFL1.
How do viruses evade the antiviral innate immune response?
Viruses evade innate immunity through mechanisms such as autophagy induction by SFTSV NSs, mitophagy induction by influenza A nucleoprotein, and deubiquitination of host signaling proteins by viral deubiquitinases.
What is the role of STING in antiviral innate immunity?
STING1 is an adaptor protein in cytosolic DNA sensing that activates TBK1-IRF3 signaling, and its stability is maintained by UFL1 to promote antiviral immunity.
How is the antiviral innate immune response regulated?
It is regulated by post-translational modifications including ubiquitination and deubiquitination, protein stability control, and autophagy or mitophagy pathways.
Which diseases are linked to antiviral innate immune response dysfunction?
Dysregulation is linked to severe COVID-19, inflammasome-mediated hyperinflammation, and viral immune evasion in chronic infections.
What methods are used to study antiviral innate immune response?
Common methods include RNA-seq, Western blot, immunoprecipitation, fluorescence microscopy, CRISPR screening, reporter assays, and inflammasome assays.
Can CRISPR be used to study antiviral innate immunity?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are widely used to dissect gene function in antiviral innate immunity.
What is the role of RNA polymerase III in antiviral innate immunity?
RNA polymerase III can sense viral DNA and produce RNA ligands that activate innate immune signaling, contributing to antiviral defense.
How does inflammasome activation relate to antiviral innate immunity?
Inflammasome activation during SARS-CoV-2 infection contributes to antiviral defense but can also drive inflammatory pathology.
Conclusion
GO:0140374 antiviral innate immune response is a fundamental biological process that protects hosts from viral infection through germline-encoded sensing and effector mechanisms. Its molecular components, including STING1, MAVS, TBK1, IRF3, and interferon-stimulated genes, are conserved across vertebrates and are subject to complex regulation and viral evasion. Dysregulation of this response contributes to severe viral disease and inflammatory pathology, making it a critical area of research. CRISPR-based cell models, including knockout, point-mutation, knock-in, and overexpression, provide powerful tools to dissect the causal roles of individual genes in antiviral innate immunity. Combined with transcriptomics, proteomics, imaging, and library screening, these approaches accelerate the discovery of host-directed antiviral targets and biomarkers.
References
- 1. Li ZM et al.. 2024. Bunyavirus SFTSV NSs utilizes autophagy to escape the antiviral innate immune response.. Autophagy 20(10):2133-2145 PMID: 38762760
- 2. Jarrous N et al.. 2021. RNA polymerase III and antiviral innate immune response.. Transcription 12(1):1-11 PMID: 33622180
- 3. Zhang B et al.. 2023. The nucleoprotein of influenza A virus inhibits the innate immune response by inducing mitophagy.. Autophagy 19(7):1916-1933 PMID: 36588386
- 4. Ortega-Villaizan MDM et al.. 2022. Fish Innate Immune Response to Viral Infection-An Overview of Five Major Antiviral Genes.. Viruses 14(7) PMID: 35891526
- 5. Zhou Z et al.. 2022. Viral deubiquitinases and innate antiviral immune response in livestock and poultry.. J Vet Med Sci 84(1):102-113 PMID: 34803084
- 6. Tao Y et al.. 2023. UFL1 promotes antiviral immune response by maintaining STING stability independent of UFMylation.. Cell Death Differ 30(1):16-26 PMID: 35871231
- 7. Yang H et al.. 2020. SARS-CoV-2 infection and the antiviral innate immune response.. J Mol Cell Biol 12(12):963-967 PMID: 33377937
- 8. Islamuddin M et al.. 2022. Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection.. Inflammation 45(5):1849-1863 PMID: 35953688
